Showing 10 posts of 25 posts found.


Sacklers accused of personally directing deceptive OxyContin sales tactics

January 17, 2019
Sales and Marketing OxyContin, Purdue Pharma, opidois, opioid crisis, pain, sackler

Members of the billionaire Sackler dynasty personally directed efforts to mislead doctors and patients as to the dangers of the …


Alabama’s biggest insurer will no longer cover OxyContin prescriptions

November 9, 2018
Medical Communications Alabama, Blue Cross and Blue Shield, OxyContin, insurance, opioids

The state of Alabama’s biggest insurer Blue Cross and Blue Shield will no long cover opioid painkiller OxyContin. The decision …

Purdue-owning Sackler family own second opioid drug maker, FT reveals

September 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing OxyContin, Purdue Pharma, opioid, opioid crisis, sackler

The billionaire Sackler family, the owners of OxyContin drugmaker Purdue Pharma, have been revealed to own a second opioid drug …


Top Ten most popular articles on Pharmafile.com this week

August 17, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, CMO, Litigation, OxyContin, Purdue Pharma, approvals, top 10

This week’s pharmaceutical headlines were dominated by legal spats as the state of New York sued OxyContin drug maker Purdue …

New York sues Purdue Pharma over opioid crisis

August 15, 2018
Research and Development Litigation, New York, OxyContin, Purude pharma, opioid crisis, state

New York State have sued OxyContin drug maker Purdue Pharma over allegations surrounding widespread fraud and deception in the marketing …

Letters to doctors reduce opioid prescriptions, study shows

August 10, 2018
Medical Communications OxyContin, USA, fentanyl, opioid, opioid crisis, research, study

A study has shown that Doctors who received a letter from the medical examiner’s office informing them of their patient’s …


Makers of immediate-release opioids must fund training on their use, FDA says

September 29, 2017
Medical Communications FDA, OxyContin, opioids, pharma, pharmaceuticals, vicodin

As part of its ongoing response to the opioid crisis in the US which is claiming the lives of over …


US city takes drug company to court over opioid crisis

March 16, 2017
Medical Communications OxyContin, opioid, opioid crisis

The opioid crisis in North America continues to rumble on, ruining lives and causing untold damage to communities. One city, …


J&J and Purdue settle Kentucky lawsuits for $39.5 million

December 24, 2015
Sales and Marketing Johnson and Johnson, Kentucky, OxyContin, Purdue Pharma, Risperdal, lawsuits

Johnson & Johnson and Purdue Pharma have settled separate lawsuits with the US state of Kentucky for a total of …


FDA approves limited OxyContin use in children

August 17, 2015
Sales and Marketing FDA, OxyContin, Purdue, Purdue Pharma, oxycodone

The FDA has approved the limited use of the strong painkiller Oxycontin for children in the US aged between 11 …

Latest content